Life sciences tools Life Sciences Solutions segment income margin measures segment income as a percentage of segment revenue under Thermo Fisher Scientific's management reporting definition.
Thermo Fisher reported a 37.0% Life Sciences Solutions segment income margin in the second quarter of 2026, compared with 36.8% a year earlier.
Productivity offset acquisition and mix pressure
Thermo Fisher said very strong productivity improved the margin, while the filtration and separation acquisition and unfavorable business mix partly offset that benefit.
The result shows why segment profitability should be evaluated separately from the headline 13% reported revenue increase.
The margin is not a standardized life-sciences peer metric
Thermo Fisher excludes specified charges and credits when evaluating segment operating performance.
Read the margin with Life Sciences Solutions organic revenue growth and bioproduction growth contribution.
Primary source: Thermo Fisher Scientific Q2 2026 Form 10-Q.
Part of the Life Sciences Tools & Biopharma Services Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- TMOOpen operating-model research →10 of 10 reviewed concepts in Life Sciences Tools & Biopharma Services EconomicsSegment income conversion4 of 4 bridge concepts supportedContinue through this bridge:Analytical Instruments MarginLab Products & Biopharma MarginSpecialty Diagnostics Margin
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare Life Sciences Solutions margins
Compare segment-income margins while preserving productivity, acquisition, mix, and issuer-defined segment accounting.
Explore more topics in the Financial Research Encyclopedia.